StockData
MAIA Biotechnology, Inc. logo

MAIA Biotechnology, Inc. (MAIA) stock

MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$1.30+0.05 (+4.00%)

Close on Nov 18, 2026Market cap $79.07MP/E –Yield –

MAIA Biotechnology total assets

Total assets on the balance sheet at the end of each period.

MAIA Biotechnology's total assets was $28.24M at Jun 30, 2026. For fiscal 2025 it was $9.70M, down 4.4% from the year before. The highest annual figure on record is $12.02M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.70M-4.4%
FY2024Dec 31, 2024$10.16M+34.2%
FY2023Dec 31, 2023$7.57M-37.1%
FY2022Dec 31, 2022$12.02M+6.1%
FY2021Dec 31, 2021$11.33M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$28.24M+155.7%
Q1 FY2026Mar 31, 2026$35.32M+197.7%
Q4 FY2025Dec 31, 2025$9.70M-4.4%
Q3 FY2025Sep 30, 2025$11.78M+27.5%
Q2 FY2025Jun 30, 2025$11.05M-8.1%
Q1 FY2025Mar 31, 2025$11.86M+36.1%
Q4 FY2024Dec 31, 2024$10.16M+34.2%
Q3 FY2024Sep 30, 2024$9.24M+32.0%
Q2 FY2024Jun 30, 2024$12.02M+17.1%
Q1 FY2024Mar 31, 2024$8.72M-3.9%
Q4 FY2023Dec 31, 2023$7.57M-37.1%
Q3 FY2023Sep 30, 2023$7.00M-52.6%
Q2 FY2023Jun 30, 2023$10.27M+5.2%
Q1 FY2023Mar 31, 2023$9.07M-19.9%
Q4 FY2022Dec 31, 2022$12.02M–
Q3 FY2022Sep 30, 2022$14.78M–
Q2 FY2022Jun 30, 2022$9.76M–
Q4 FY2021Dec 31, 2021$11.33M–

More MAIA Biotechnology figures

See a number that looks wrong?